Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead Partners With Tentarix In Platform Discovery Deal

Aug 15 2023

• By Jessica Merrill

multi target approach — Gilead partners on multi-target antibody technology • Source: Shutterstock

Related Content

Deal With Gilead For Anti-CD123 Bispecific Offers Breath Of Fresh Air For MacroGenics

Oct 17 2022

Related Companies

Gilead Sciences, Inc.

Tentarix Biotherapeutics LP

Macrogenix B.V.

Additional Topics

Deals Platform Technologies Research & Development Business Strategies BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.